Depression Blood Test Breakthrough: Immune Cell Aging May Detect the Disorder Before Symptoms Spiral

# Depression Blood Test Breakthrough: Immune Cell Aging May Detect the Disorder Before Symptoms Spiral

> **Quick answer:** A May 2026 study from NYU, published in *The Journals of Gerontology*, found that accelerated aging in monocytes — white blood cells measurable through a standard blood draw — reliably predicts the emotional and cognitive symptoms of depression, including hopelessness and anhedonia. This is the first objective biological marker tied specifically to non-somatic depression, and it could eventually replace the years of trial-and-error that define current diagnosis.

Depression may soon be detectable through a blood test that tracks how fast your immune cells are aging — and a major new study says the signal is already measurable before patients spiral into crisis. Researchers identified a specific type of white blood cell whose accelerated biological aging maps closely to the emotional core of depression, offering the first truly objective biomarker for a disorder that has resisted them for decades.

## The Study: What Researchers Found

Published May 4, 2026 in *The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences*, the study was led by Nicole Beaulieu Perez, Assistant Professor at NYU Rory Meyers College of Nursing, with collaborators from Yale, Johns Hopkins, Albert Einstein College of Medicine, and the University of Miami.

The research drew on data from 440 women enrolled in the Women's Interagency HIV Study — 261 living with HIV and 179 without. Participants completed the Center for Epidemiologic Studies Depression Scale (CES-D), a validated 20-item questionnaire that distinguishes between somatic symptoms (fatigue, appetite loss, sleep problems) and non-somatic, or cognitive-emotional, symptoms (anhedonia, hopelessness, feelings of failure).